PharmaBlock Sciences Nanjing Inc Class A (300725) — Tangible Net Worth Ratio
PharmaBlock Sciences Nanjing Inc Class A (300725) has a Tangible Net Worth Ratio of 98.5% as of September 2025. This metric is calculated by deducting intangible assets (CN¥103.78 Million) from net assets (CN¥7.15 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 300725 book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
PharmaBlock Sciences Nanjing Inc Class A Tangible Net Worth Ratio (2013–2024)
This chart shows how PharmaBlock Sciences Nanjing Inc Class A's Tangible Net Worth Ratio has changed across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 98.5%, reflecting net assets of CN¥7.15 Billion with intangible assets of CN¥103.78 Million CNY. Also explore net asset momentum of PharmaBlock Sciences Nanjing Inc Class A to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for PharmaBlock Sciences Nanjing Inc Class A (2013–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for PharmaBlock Sciences Nanjing Inc Class A from 2013 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of PharmaBlock Sciences Nanjing Inc Class A.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 96.4% | CN¥2.99 Billion | CN¥107.98 Million | CN¥4.94 Billion | ▲ +0.2 pp |
| 2023 | 96.1% | CN¥2.83 Billion | CN¥109.42 Million | CN¥5.10 Billion | ▲ +0.3 pp |
| 2022 | 95.8% | CN¥2.66 Billion | CN¥111.48 Million | CN¥4.86 Billion | ▲ +0.0 pp |
| 2021 | 95.8% | CN¥2.63 Billion | CN¥111.47 Million | CN¥3.51 Billion | ▼ -2.5 pp |
| 2020 | 98.2% | CN¥1.89 Billion | CN¥33.83 Million | CN¥2.43 Billion | ▲ +1.6 pp |
| 2019 | 96.6% | CN¥740.87 Million | CN¥25.12 Million | CN¥1.03 Billion | ▲ +0.6 pp |
| 2018 | 96.0% | CN¥599.73 Million | CN¥24.09 Million | CN¥761.16 Million | ▼ -0.1 pp |
| 2017 | 96.0% | CN¥503.59 Million | CN¥19.98 Million | CN¥567.40 Million | ▼ -0.2 pp |
| 2016 | 96.3% | CN¥254.15 Million | CN¥9.51 Million | CN¥299.15 Million | ▼ -2.4 pp |
| 2015 | 98.7% | CN¥146.56 Million | CN¥1.93 Million | CN¥172.48 Million | ▲ +1.0 pp |
| 2014 | 97.7% | CN¥87.18 Million | CN¥2.01 Million | CN¥101.56 Million | ▲ +0.6 pp |
| 2013 | 97.1% | CN¥70.16 Million | CN¥2.07 Million | CN¥85.13 Million | — |